The LAM Institute is a research organization focused on advancing knowledge and treatment options for Lymphangioleiomyomatosis (LAM), a rare lung disease that primarily affects women. The institute aims to promote scientific research, support clinical trials, and provide resources for patients and healthcare professionals. In addition to research, the LAM Institute offers educational programs and outreach initiatives to raise awareness about the disease. They collaborate with various stakeholders, including medical professionals, researchers, and patient advocacy groups, to improve the understanding and management of LAM, ultimately enhancing the quality of life for those affected.